Drug discovery

Recent Course X grad named one of Forbes magazine's '30 Under 30'Pedro Valencia PhD '12 honored for drug research.

How better financing could help create new cancer drugsMIT finance researchers say a diversified ‘megafund’ of securities could help the industry deliver new products to consumers.

Piece by pieceMIT biologist Schwartz relishes the challenge of picking apart the cell’s most complex structure.

Predicting how proteins will partnerAmy Keating models critical interactions that underlie most cellular functions.

Going with the flowNew 3-D microfluidic system offers greater control over production of drug-delivering nanoparticles.

Getting bacteria to do a plant’s jobResearchers engineer microbes for low-cost production of precursor of anticancer drug Taxol and other pharmaceuticals.

An easier way to synthesize new drug candidatesMIT chemists’ answer to long-standing problem could have a big impact on pharmaceutical business.

Why cancer drugs lose their powerMIT biologists show how tumors can become resistant to the commonly used chemotherapy drug cisplatin.

Drug discovery, Netflix style?MIT researchers apply ranking algorithms to pharmaceutical R&D.